Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe crawled date : 2021 - 06 - 25 save search
Vertex Announces New Portfolio Reimbursement Agreement in Italy Including KAFTRIO®, SYMKEVI® and Additional Indications of ORKAMBI® and KALYDECO® for Eligible Patients With Cystic Fibrosis
Published: 2021-06-25 (Crawled : 21:00) - biospace.com/
VRTX | $400.66 -1.05% -1.06% 810K
|
Health Technology
|
| O: 0.03%
H: 1.45%
C: 1.22%
fibrosis cystic fibrosis
Incyte and MorphoSys Announce Positive CHMP Opinion for Tafasitamab in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published: 2021-06-25 (Crawled : 12:15) - biospace.com/
XNCR | $19.05 3.7% 3.57% 760K
|
Health Technology
|
| O: 0.06%
H: 2.35%
C: 0.75%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 2.89%
H: 0.23%
C: -0.55%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.71%
H: 1.74%
C: 1.53%
treatment positive chmp t-cell
BioMarin Receives Positive CHMP Opinion in Europe for Vosoritide for the Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Published: 2021-06-25 (Crawled : 12:00) - investors.biomarin.com
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: 0.66%
H: 1.39%
C: 0.55%
treatment europe drop positive children growth chmp achondroplasia
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
Published: 2021-06-25 (Crawled : 10:00) - biospace.com/
AUPH | $5.03 -1.18% -1.19% 790K
|
Health Technology
|
| O: 0.0%
H: 2.77%
C: -0.97%
europe license authorized ema application
Libtayo® (cemiplimab) Approved by the European Commission for First-Line Treatment of Patients with Advanced Non-small Cell Lung Cancer with ≥50% PD-L1 Expression
Published: 2021-06-25 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
treatment lung cancer europe cancer
Libtayo® (cemiplimab) Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma
Published: 2021-06-25 (Crawled : 06:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
immunotherapy europe therapy cell carcinoma
Industrial Robotics Market in Europe in Industrial Machinery Sector: Incremental Growth is Expected to be Worth $ 2.51 Billion by 2025
Published: 2021-06-25 (Crawled : 06:00) - prnewswire.com
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 0.87%
H: 0.12%
C: -0.32%
europe growth trial
Sanofi: Libtayo® (cemiplimab) approved by the European Commission for first-line treatment of patients with advanced non-small cell lung cancer with ≥50% PD-L1 expression
Published: 2021-06-25 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
treatment lung cancer europe cancer
Sanofi: Libtayo® (cemiplimab) approved by the European Commission as the first immunotherapy indicated for patients with advanced basal cell carcinoma
Published: 2021-06-25 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.55%
H: 0.68%
C: 0.57%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.16%
H: 1.64%
C: 1.28%
immunotherapy europe therapy cell carcinoma
CPhI report predicts ‘supercharged partnering’ in USA Pharma sector over the next 18-months
Published: 2021-06-24 (Crawled : 00:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.2%
H: 0.69%
C: 0.07%
pharma
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.